4.6 Review

Retinal Prostheses: Current Clinical Results and Future Needs

Journal

OPHTHALMOLOGY
Volume 118, Issue 11, Pages 2227-2237

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ophtha.2011.08.042

Keywords

-

Categories

Funding

  1. Second Sight Medical Products, Inc.
  2. National Science Foundation, Arlington, Virginia [EEC-0310723]
  3. Department of Energy, Washington, DC [DE-FC02-04ER63735]

Ask authors/readers for more resources

Degenerative diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP) primarily affect the photoreceptors, ultimately resulting in significant loss of vision. Retinal prostheses aim to elicit neural activity in the remaining retinal cells by detecting and converting light into electrical stimuli that can then be delivered to the retina. The concept of visual prostheses has existed for more than 50 years and recent progress shows promise, yet much remains to be understood about how the visual system will respond to artificial input after years of blindness that necessitate this type of prosthesis. This review focuses on 3 major areas: the histopathologic features of human retina affected by AMD and RP, current results from clinical trials, and challenges to overcome for continued improvement of retinal prostheses. Financial Disclosure(s) Proprietary or commercial disclosures may be found after the references. Ophthalmology 2011;118:2227-2237 (C) 2011 by the American Academy of Ophthalmology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available